Health and Me

Rachel V Thomas

US FDA Asks Lilly To Share More Health Safety Data On Weight Loss Pill Foundayo

Weeks after the US Food and Drug Administration (<span>FDA</span>) approved <span>Eli Lilly</span>'s <span>Orforglipron</span>, marketed as <span>Foundayo</span>, the regulator is asking Eli <span>Lilly</span> to share more safety data on its first oral pill for weight loss.

The FDA has also sought more information on whether Foundayo could be linked to liver and heart problems, according to the FDA's new drug application approval letter.

Foundayo won FDA approval this month under the Commissioner’s National Priority Voucher, a pilot program intended to fast-track drug reviews.

<h2>Foundayo: What More Does The FDA Want From Lilly </h2>

In the approval letter, the FDA noted that the currently available data do not fully clarify several potential risks, including 

<ul><li>heart problems such as heart attack and stroke, </li><li>drug-induced liver injuries, </li><li>delayed stomach emptying, which is when food remains in the stomach for too long.</li></ul>

However, the FDA asking for more data “doesn’t mean a safety problem has been found. It means they want more definitive long-term data,” Dr. Christopher McGowan, a North Carolina-based gastroenterologist, told NBC News.

“With orforglipron, it’s a newer, non-peptide version of a GLP-1, so we don’t yet have the same depth of safety data as the injectables,” he added.

<strong>Also read: </strong><a href="https://www.healthandme.com/health-news/eye-drops-us-fda-recalls-over-3-million-products-over-safety-concerns-article-153994270" data-type="tilCustomLink">Eye Drops: US FDA Recalls Over 3 Million Products Over Safety Concerns</a>

Further, the agency also requires Lilly to run a series of new studies, including a registry tracking children with obesity who use weight loss drugs and a pregnancy registry to monitor outcomes.

<h2>Foundayo: How Did The FDA Approve?</h2>

In a statement, the <span>US FDA</span> said that "Foundayo has been approved for use in combination with a reduced-calorie diet and increased physical activity. The pill is targeted to reduce excess body weight and maintain weight reduction for the long term in adults with obesity or overweight".

The <a href="https://www.healthandme.com/health-news/foundayo-us-fda-approves-eli-lillys-glp-1-weight-loss-pill-article-153979432" data-type="tilCustomLink">US FDA approved Foundayo </a> after two randomized, double-blind, placebo-controlled trials in adults with obesity or overweight showed benefit.

In these trials, 72 weeks of treatment with Foundayo, in combination with a reduced-calorie diet and increased physical activity, resulted in a statistically significant and clinically meaningful reduction in body weight.

Foundayo’s approval comes after the US FDA in December last year approved <span>Novo Nordisk</span>’s Wegovy pill — the first-ever GLP-1 pill for weight loss. The Danish drugmaker rolled out the pill in January this year.

Novo Nordisk was also the first to launch oral GLP 1 Rybelsus to treat type 2 diabetes. It was approved by the US FDA in September 2019.

<strong>Also read:</strong> <a href="https://www.healthandme.com/health-news/us-fda-recalls-china-made-cough-drops-and-throat-lozenges-article-154074492" data-type="tilCustomLink">US FDA Recalls China-made Cough Drops And Throat Lozenges</a>

<h2>How Did Lilly React To The FDA's Query?</h2>

The FDA’s post-approval requirements are routine and consistent with the agency’s approach to ongoing safety reviews of newly approved drugs, according to a Lilly spokesperson, NBC News reported.

“Patient safety is Lilly’s top priority, and we actively monitor, evaluate, and report safety information for all our medicines,” the spokesperson said.

Meanwhile, Lilly has started selling the drug from April 6 through its direct-to-consumer platform LillyDirect at $149 per month for the lowest dose for self-pay customers, on par with Novo's pill. "Shortly after,” it will be available through retail pharmacies and telehealth providers in the US, as per Lilly.

Health Conditions A-Z

health

us-fda-asks-lilly-to-share-more-health-safety-data-on-weight-loss-pill-foundayo

lilly

foundayo

novo nordisk

us fda

orforglipron

eli lilly

india-introduces-healthy-lifestyle-mental-wellness-as-priority-areas-at-brics-meet

India Introduces Healthy Lifestyle, Mental Wellness as Priority Areas at BRICS Meet

hernia-surgery

Have Hernia Surgeries Become Less Painful?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Weeks after the US Food and Drug Administration (FDA) approved Eli Lilly's Orforglipron, marketed as Foundayo, the regulator is asking Eli Lilly to share more safety data on its first oral pill for weight loss.The FDA has also sought more information on whether Foundayo could be linked to liver and heart problems, according to the FDA's new drug application approval letter.Foundayo won FDA approval this month under the Commissioner’s National Priority Voucher, a pilot program intended to fast-track drug reviews.Foundayo: What More Does The FDA Want From Lilly In the approval letter, the FDA noted that the currently available data do not fully clarify several potential risks, including heart problems such as heart attack and stroke, drug-induced liver injuries, delayed stomach emptying, which is when food remains in the stomach for too long.However, the FDA asking for more data “doesn’t mean a safety problem has been found. It means they want more definitive long-term data,” Dr. Christopher McGowan, a North Carolina-based gastroenterologist, told NBC News.“With orforglipron, it’s a newer, non-peptide version of a GLP-1, so we don’t yet have the same depth of safety data as the injectables,” he added.Also read: Eye Drops: US FDA Recalls Over 3 Million Products Over Safety ConcernsFurther, the agency also requires Lilly to run a series of new studies, including a registry tracking children with obesity who use weight loss drugs and a pregnancy registry to monitor outcomes.Foundayo: How Did The FDA Approve?In a statement, the US FDA said that "Foundayo has been approved for use in combination with a reduced-calorie diet and increased physical activity. The pill is targeted to reduce excess body weight and maintain weight reduction for the long term in adults with obesity or overweight".The US FDA approved Foundayo  after two randomized, double-blind, placebo-controlled trials in adults with obesity or overweight showed benefit.    In these trials, 72 weeks of treatment with Foundayo, in combination with a reduced-calorie diet and increased physical activity, resulted in a statistically significant and clinically meaningful reduction in body weight.Foundayo’s approval comes after the US FDA in December last year approved Novo Nordisk’s Wegovy pill — the first-ever GLP-1 pill for weight loss. The Danish drugmaker rolled out the pill in January this year.Novo Nordisk was also the first to launch oral GLP 1 Rybelsus to treat type 2 diabetes. It was approved by the US FDA in September 2019.Also read: US FDA Recalls China-made Cough Drops And Throat LozengesHow Did Lilly React To The FDA's Query?The FDA’s post-approval requirements are routine and consistent with the agency’s approach to ongoing safety reviews of newly approved drugs, according to a Lilly spokesperson, NBC News reported.“Patient safety is Lilly’s top priority, and we actively monitor, evaluate, and report safety information for all our medicines,” the spokesperson said.Meanwhile, Lilly has started selling the drug from April 6 through its direct-to-consumer platform LillyDirect at $149 per month for the lowest dose for self-pay customers, on par with Novo's pill. "Shortly after,” it will be available through retail pharmacies and telehealth providers in the US, as per Lilly.

us fda asks lilly to share more health safety data on weight loss pill foundayo

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

US FDA Asks Lilly To Share More Health Safety Data On Weight Loss Pill Foundayo

India Introduces Healthy Lifestyle, Mental Wellness as Priority Areas at BRICS Meet

‘Enough of Toxicity, I’ll Fight It Alone,’ Says Dr Sivaranjani Santosh After Resigning from IAP | EXCLUSIVE

Iran war: Indian Govt Considering Temporary Price Hike For Essential Medicines

Health Conditions A-Z

US FDA Asks Lilly To Share More Health Safety Data On Weight Loss Pill Foundayo

India Introduces Healthy Lifestyle, Mental Wellness as Priority Areas at BRICS Meet

Have Hernia Surgeries Become Less Painful?